NICE 21 Oct 2026
XVIVO Perfusion System (ex-situ machine perfusion) for assessing and reconditioning marginal lungs for transplantation: early-use assessment
HTG784
21 Oct 2026
Read →
These trials are currently recruiting participants in the UK. Always speak to your GP or specialist before contacting a trial team.
The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential…
This study will evaluate the safety, tolerability, pharmacokinetics (PK), immunogenicity, and pharmacodynamics (PD) of single and multiple doses of RO7830698 in healthy…
The objective of this study is to assess the safety and efficacy of Apreo BREATHE system when used to support native airways…
The diagnosis of either asthma or chronic obstructive pulmonary disease (COPD) is currently based on a combination of symptoms, different lung tests…
This study evaluates the safety and tolerability of CHF10136 administered by inhalation in healthy adults and adults with asthma. The study includes…
The goal of this observational study is to learn about the short- and long-term outcomes of people admitted to hospital with an…
Salbutamol is a quick-relief (reliever) inhaler used to treat the symptoms of asthma and COPD. It…
Learn more →Your patient insight is valuable. Take a short survey and help researchers improve treatments for Lung & Breathing.
Living with Lung & Breathing? Your experience can help others. Share what you've learned.
Thousands of UK patients are managing Lung & Breathing. Connect, share experiences, and support each other.
The latest pipeline drugs, clinical breakthroughs, and regulatory approvals from the FDA, EMA and NICE for Lung & Breathing patients.
HTG784
HTG776
TA1142
📋 Information sourced from clinical trial registries, FDA, EMA and published research
View all research →No podcasts available yet for Lung & Breathing
Sign up for updates below to be notified when we release a free patient podcast for this area.